China’s first mRNA Covid-19 vaccine approved for use in Indonesia


Indonesia has become the first country to approve a Chinese home-grown mRNA Covid-19 vaccine for emergency use.

The Indonesian Food and Drugs Agency on Thursday approved AWcorna for primary and booster use by people aged 18 years old and above, according to a report in China’s Communist Party mouthpiece People’s Daily.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , Vaccine , Indonesia

Next In Aseanplus News

Indonesia’s blanket fuel subsidies favour the rich, say economists, urging targeted aid
Heavy rain warning for 48 provinces as Bangkok braces for downpours
Two men arrested for theft of diamond worth over S$235,000 at Singapore's Chinatown jewellery store
Japan foreigner entry visa fees to be hiked five-fold to US$90 from July
Australia detects first case of contagious H5 bird flu
Last-known wild Bornean rhino sought for IVF
Kashmir grounds to a halt
Trump reportedly seeking to turn attention North after Iran deal
Govt halts free meals drive during holidays
Telegram loses bid to overturn temporary blocking of the app

Others Also Read